BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16

• Press Releases

  Mighty Therapeutics Announces First Patient Dosed in Phase 4 Confirmatory Study of Elamipretide in Barth Syndrome

  July 8, 2026

   · 

  8 min read
• Press Releases

  Incyte to Report Second Quarter 2026 Financial Results

  July 8, 2026

   · 

  1 min read
• Press Releases

  Revvity to Hold Earnings Call on Tuesday, August 4, 2026

  July 8, 2026

   · 

  1 min read
• Press Releases

  Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis

  July 8, 2026

   · 

  3 min read
• Press Releases

  GE HealthCare to announce second quarter 2026 results on July 29, 2026

  July 8, 2026

   · 

  1 min read
• Press Releases

  EMD Serono Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients with Active Skin Manifestations

  July 8, 2026

   · 

  7 min read
• Press Releases

  Fonseca Biosciences Launches XTORO® (finafloxacin otic suspension) 0.3% for Acute Otitis Externa

  July 8, 2026

   · 

  4 min read
• Press Releases

  Restart Life Sciences Details Next-Generation Product Pipeline and Segment Expansion for Holy Crap

  July 8, 2026

   · 

  4 min read
• Press Releases

  Defence Therapeutics Opens New Office in Hamilton to Expand Its Accum Radiopharmaceutical Platform

  July 8, 2026

   · 

  4 min read
• Press Releases

  Vaccinex to Report New Biomarker Data and Plans for Phase 2B Clinical Trial of Pepinemab in AD at the Alzheimer’s Association International Conference in London on July 13, 2026

  July 8, 2026

   · 

  6 min read